Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Novo Nordisk Refocuses Odense Spend Toward GLP-1 Growth Priorities
Wolfe Research Says COVID Uncertainty Continues to Weigh on Pfizer (PFE) Outlook
DNB Asset Management AS Acquires 486,895 Shares of Pfizer Inc. $PFE - Stock Observer
Assessing Pfizer (PFE) Valuation After Recent Share Price Weakness And Oncology Growth Expectations
Pfizer Hemophilia Approval Expands HYMPAVZI Reach And Supports Valuation Case
Carboplatin with or without nivolumab in metastatic triple-negative breast cancer: a randomized phase II trial
Pfizer rep to FDA: New vaccine formulation was not tested, clinical studies 'not required' | Israel National News
Rigel Pharmaceuticals (RIGL) Is Up 11.4% After Licensing FDA‑Approved Breast Cancer Drug VEPPANU
Pfizer (NYSE:PFE) Trading Down 1.7% - Here's Why
5 Best Dividend Stocks with 5%+ Yields and Growing Cash Flows
Michael Burry's Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why
Pfizer Inc. $PFE Shares Sold by Pinnacle Associates Ltd.
5 Must-Read Analyst Questions From Pfizer's Q1 Earnings Call
Expert recommendations for PIK3CA testing in HR+/HER2− locally advanced and metastatic breast cancer
Israel to offer non-mRNA coronavirus vaccine
BMJ Senior Editor: COVID vaccines more likely to put you in hospital than keep you out
Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study
Epidemiological, immunological and virulence characteristics of persistent Streptococcus pneumoniae vaccine serotypes following vaccine introduction
Jim Cramer on Pfizer: "Pfizer Does Not Have Any Earnings Momentum"
World Investment Advisors Buys 40,239 Shares of Pfizer Inc. $PFE
Best Pharmaceutical Stocks To Follow Now - May 11th - Stock Observer
Rigel Pharmaceuticals (RIGL) Is Up 20.5% After Global VEPPANU Rights Deal With Pfizer, Arvinas - Has The Bull Case Changed?
Pfizer discloses new dual calcitonin/amylin receptor agonists | BioWorld
Rayburn West Financial Services LLC Buys Shares of 47,530 Pfizer Inc. $PFE - Daily Political
Should you buy pharma stocks? Dr Reddy's, Pfizer Target prices after Q4 results - BusinessToday
Pfizer Hemophilia Drug Win In Europe Adds Weight To Undervalued Thesis
Abatacept versus hydroxychloroquine for prevention of rheumatoid arthritis in individuals with palindromic rheumatism: a randomized open-label trial
Ex vivo drug screening and clustering of bladder cancers for pre-clinical treatment prediction
Valneva SE (INRLF) Q1 2026 Earnings Call Highlights: Promising Vaccine Developments Amid ...
From oncology to obesity, Pfizer bets big on India for its next growth wave
Pfizer (PFE) Expands Hympavzi Approval for Adolescent Hemophilia Treatment
3 Struggling Stocks That Could Make for Great Contrarian Buys
Pfizer (PFE) Receives EU Approval for Expanded Use of Hympavzi
Protalix BioTherapeutics Reports First Quarter 2026 Financial an
European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors
Pfizer Shifts VEPPANU Rights To Rigel As Valuation Gap Persists
Despite heavy Q4 profit slump, hefty dividend of Rs 75 per share declared Record date fixed - BusinessToday
Patrick M Sweeney & Associates Inc. Sells 20,492 Shares of Pfizer Inc. $PFE - Stock Observer
Valneva publie ses résultats financiers audités et consolidés pour le premier trimestre 2026
Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates
Pfizer PROTAC Licensing Deal With Rigel Adds Royalties To Valuation Story
Board of Pfizer recommends final dividend
Pfizer AGM scheduled
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO): 2026 update
Report: Ministry of Health contacted Pfizer regarding COVID pill
Dave Rubin: Pfizer conflict of interest in plain sight
Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma
Pfizer (PFE) Enters Licensing Deal with Rigel Pharmaceuticals
Arvinas Inc (ARVN) Q1 2026 Earnings Call Highlights: Strategic Advances Amid Revenue Decline
Pfizer (PFE) Partners with Arvinas for Veppanu Development
This 1 Insane Nvidia Stat Explains Why Wall Street Can't Stop Buying the Stock
Q4 Results Today Highlights: MobiKwik Q4 profit dips q-o-q, Tata Power, Dr Reddy's, Torrent Power, Dixon Tech, Max Financial, Berger Paints, Pfizer, Sagility, MTAR Tech, V-Guard, Inox India, Nazara, Texmaco Rail announce Q4 results
Veppanu deal between Rigel and Arvinas, Pfizer worth up to $445M | BioWorld
PFE Enters Global License Agreement for Innovative Drug Development
Pfizer Standalone March 2026 Net Sales at Rs 629.23 crore, up 6.31% Y-o-Y
3 Berkshire Stocks Under $30 and 2 Under $30 Greg Abel May Buy
Arvinas, Pfizer Tap Rigel Pharmaceuticals to Bring Veppanu to Market | Morningstar
Q4 Results Today Live: Tata Power, Dr Reddy's, Torrent Power, Dixon Tech, Max Financial, Berger Paints, Pfizer, Sagility, MTAR Tech, V-Guard, Inox India, Nazara, Texmaco Rail to announce Q4 results, Canara Bank, JSW Energy, PVR Inox, Nuvama, UPL, JBM Auto shares in focus
E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer
FDA Seeks Input on Drug Repurposing for Chronic Diseases
How Relay's Phase 3 Zovegalisib Breast Cancer Push Could Reshape Relay Therapeutics' (RLAY) Investment Story
Novavax (NVAX) Is Up 25.9% After Pfizer Matrix-M Deal And Q1 Beat On Expectations - What's Changed
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
Atgam (Pfizer) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
Pfizer vs Eli Lilly: Different Bets on Pharma M&A - 24/7 Wall St.
Pfizer vs Eli Lilly: Different Bets on Pharma M&A - AOL
Pfizer Inc. $PFE Shares Purchased by Swiss Life Asset Management Ltd
49,073 Shares in Pfizer Inc. $PFE Bought by Manning & Napier Advisors LLC
Novavax (NVAX) Valuation Check After Pfizer Licensing Deal And Partnership-Led Earnings Beat
FY2027 EPS Estimates for Pfizer Boosted by Erste Group Bank
Swiss Life Asset Management Ltd Boosts Position in Pfizer Inc. $PFE - Daily Political
Pfizer Inc. $PFE Shares Sold by Kepler Cheuvreux Suisse SA - Daily Political
Securian Asset Management Inc. Sells 119,974 Shares of Pfizer Inc. $PFE - Daily Political
Positron-emission tomography as a predictor of response to first-line cyclin-dependent kinase 4/6 inhibitors in patients with metastatic ER-positive HER2-negative breast cancer
What Pfizer (PFE)'s Earnings Beat, Reaffirmed Guidance and Oncology Wins Mean For Shareholders - Simply Wall St News
Bust Fake News With Bangalore Mirror: Hantavirus infection is not a confirmed side effect of Pfizer's COVID-19 vaccine
Fact Check: Hantavirus infection is not a confirmed side effect of Pfizer's COVID-19 vaccine
Pfizer (PFE) Beats EPS Estimates, Reaffirms Full-Year Outlook
Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?
Promising Pharmaceutical Stocks To Watch Now - May 9th - Stock Observer
F m Investments LLC Has $7.39 Million Holdings in Pfizer Inc. $PFE - Stock Observer
Pharmaceutical Stocks Worth Watching - May 6th - Daily Political
Pfizer (NYSE:PFE) Raised to "Buy" at Wall Street Zen
Pfizer Inc. $PFE Shares Purchased by Cheviot Value Management LLC - Stock Observer
Here is Why Pfizer (PFE) One of the Best High Volume Stocks to Invest In
Jefferies Sticks to Its Buy Rating for arGEN X (0QW0)
Risk factors and metastatic sites in HER2-positive breast cancer with pathological complete response
Pfizer (NYSE:PFE) Stock Price Down 3.1% - Time to Sell?
Fact Check: Pfizer didn't say hantavirus is side effect of its COVID-19 vaccine, contrary to online claims - Yahoo News Canada
Guardant Health (GH) Announces Departure of Chief Medical Officer
Weekly Buzz:FDA Clears Tab-cel Path, Arvinas Wins PROTAC Nod, Novartis Cuts Jobs, Roche Buys PathAI
Pfizer Inc. $PFE Shares Purchased by Generali Asset Management SPA SGR
Assessing Pfizer's (PFE) Valuation As Shares Hover Near Recent Levels
